Application

EXSCISSOR

Intellia Therapeutics, Inc.

Trademark/Service Mark Application, Principal Register

PTO- 1478
Approved for use through 10/31/2024. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

Trademark/Service Mark Application, Principal Register

Serial Number: 98623888
Filing Date: 06/28/2024

The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 98623888
MARK INFORMATION
*MARK EXSCISSOR
STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
LITERAL ELEMENT EXSCISSOR
MARK STATEMENT The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER Principal
APPLICANT INFORMATION
*OWNER OF MARK Intellia Therapeutics, Inc.
*MAILING ADDRESS 40 Erie Street
*CITY Cambridge
*STATE
(Required for U.S. applicants)
Massachusetts
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
02139
*EMAIL ADDRESS XXXX
LEGAL ENTITY INFORMATION
TYPE corporation
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION Delaware
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS 042 
*IDENTIFICATION Research and development in the field of gene, genome, or cellular editing technology for medical purposes
FILING BASIS SECTION 1(b)
INTERNATIONAL CLASS 044 
*IDENTIFICATION Medical treatment of diseases using gene, genome, or cellular editing therapies
FILING BASIS SECTION 1(b)
INTERNATIONAL CLASS 045 
*IDENTIFICATION Licensing of technology in the field of gene, genome, or cellular editing for medical or research purposes; licensing of intellectual property rights related to gene, genome, or cellular editing technology
FILING BASIS SECTION 1(b)
ATTORNEY INFORMATION
NAME Jonathan M. Gelchinsky
ATTORNEY DOCKET NUMBER 33485/6220
ATTORNEY BAR MEMBERSHIP NUMBER XXX
YEAR OF ADMISSION XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY XX
FIRM NAME Pierce Atwood LLP
STREET 254 Commercial Street
CITY Portland
STATE Maine
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
ZIP/POSTAL CODE 04101
PHONE 207-791-1100
FAX 207-791-1350
EMAIL ADDRESS trademark@pierceatwood.com
OTHER APPOINTED ATTORNEY each of the attorneys of Pierce Atwood LLP
CORRESPONDENCE INFORMATION
NAME Jonathan M. Gelchinsky
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE trademark@pierceatwood.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) NOT PROVIDED
FEE INFORMATION
APPLICATION FILING OPTION TEAS Standard
NUMBER OF CLASSES 3
APPLICATION FOR REGISTRATION PER CLASS 350
*TOTAL FEES DUE 1050
*TOTAL FEES PAID 1050
SIGNATURE INFORMATION
SIGNATURE /Carol Loeschorn/
SIGNATORY'S NAME Carol Loeschorn
SIGNATORY'S POSITION VP, Intellectual Property
SIGNATORY'S PHONE NUMBER 000-000-0000
DATE SIGNED 06/28/2024
SIGNATURE METHOD Sent to third party for signature



PTO- 1478
Approved for use through 10/31/2024. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number


Trademark/Service Mark Application, Principal Register

Serial Number: 98623888
Filing Date: 06/28/2024

To the Commissioner for Trademarks:

MARK: EXSCISSOR (Standard Characters, see mark)
The literal element of the mark consists of EXSCISSOR. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, Intellia Therapeutics, Inc., a corporation of Delaware, having an address of
      40 Erie Street
      Cambridge, Massachusetts 02139
      United States
      XXXX

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

International Class 042:  Research and development in the field of gene, genome, or cellular editing technology for medical purposes
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

International Class 044:  Medical treatment of diseases using gene, genome, or cellular editing therapies
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

International Class 045:  Licensing of technology in the field of gene, genome, or cellular editing for medical or research purposes; licensing of intellectual property rights related to gene, genome, or cellular editing technology
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.



The owner's/holder's proposed attorney information: Jonathan M. Gelchinsky. Other appointed attorneys are each of the attorneys of Pierce Atwood LLP. Jonathan M. Gelchinsky of Pierce Atwood LLP, is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, and the attorney(s) is located at
      254 Commercial Street
      Portland, Maine 04101
      United States
      207-791-1100(phone)
      207-791-1350(fax)
      trademark@pierceatwood.com
The docket/reference number is 33485/6220.
Jonathan M. Gelchinsky submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S. Commonwealth or territory.
The applicant's current Correspondence Information:
      Jonathan M. Gelchinsky
       PRIMARY EMAIL FOR CORRESPONDENCE: trademark@pierceatwood.com       SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): NOT PROVIDED


Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $1050 has been submitted with the application, representing payment for 3 class(es).

Declaration

Declaration Signature

Signature: /Carol Loeschorn/   Date: 06/28/2024
Signatory's Name: Carol Loeschorn
Signatory's Position: VP, Intellectual Property
Signatory's Phone Number: 000-000-0000
Signature method: Sent to third party for signature
Payment Sale Number: 98623888
Payment Accounting Date: 06/28/2024

Serial Number: 98623888
Internet Transmission Date: Fri Jun 28 09:25:47 ET 2024
TEAS Stamp: USPTO/BAS-XX.XX.XXX.XXX-2024062809254788
7114-98623888-87088cb911ee221424f9630116
b88ed5d1c6ace92bf477bbd95d12430a333cdbc6
8-DA-25477226-20240627151614545865

Application [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed